Sign In
Buy OPY
$99.90
+2.52 (+2.59%)
At Close: Jun 09, 2026
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
07:30am, Tuesday, 17'th Feb 2026
NEW HAVEN, Conn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphi
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
07:01am, Tuesday, 17'th Feb 2026
Pasithea Therapeutics (Nasdaq: KTTA) will present to Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 25, 2026, 4:00 PM ET
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
08:00am, Thursday, 12'th Feb 2026
NORWOOD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D.
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
07:45am, Thursday, 12'th Feb 2026
TAMPA, Fla., Feb. 12, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance t
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
08:45am, Thursday, 05'th Feb 2026
Virtual presentation scheduled for Thursday, February 26 th at 12:40 PM ET Access the webcast here Carlsbad, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or
Oppenheimer Holdings: Public Markets Come Back, Driving ECM And Profits
12:01am, Thursday, 05'th Feb 2026
Oppenheimer Holdings delivered strong quarterly results, driven by operating leverage and a sharp rebound in capital markets, particularly ECM. Wealth management benefited from higher AUM and a favora
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
07:00am, Wednesday, 04'th Feb 2026
JUPITER, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza wi
Oppenheimer (NYSE:OPY) Reaches New 1-Year High – What’s Next?
01:21am, Monday, 02'nd Feb 2026
Oppenheimer Holdings, Inc. (NYSE: OPY - Get Free Report) hit a new 52-week high during mid-day trading on Saturday. The stock traded as high as $86.69 and last traded at $84.1950, with a volume of 932
Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings
08:00am, Friday, 30'th Jan 2026
/CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the
M-tron Industries, Inc. to Host 1x1 Investor Meetings at the Oppenheimer 11th Annual Emerging Growth Conference on February 3, 2026
04:30pm, Wednesday, 28'th Jan 2026
ORLANDO, Fla., Jan. 28, 2026 /PRNewswire/ -- M-tron Industries, Inc. (NYSE American: MPTI) ("Mtron" or the "Company") is pleased to announce that Cameron Pforr, Chief Executive Officer, and other me
InTest Corporation to Participate in the Oppenheimer 11th Annual Emerging Growth Conference
08:00am, Wednesday, 28'th Jan 2026
MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target ma
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism
06:38am, Wednesday, 28'th Jan 2026
Relay Therapeutics is upgraded to Outperform with a $14 price target, driven by optimism for zovegalisib in PIK3CA-mutant HR+/HER2- metastatic breast cancer. Zovegalisib's mutant-selective PI3Kα inhi
eGain to Participate in the Oppenheimer Emerging Growth Conference on February 4, 2026
06:30am, Wednesday, 28'th Jan 2026
SUNNYVALE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), a leading provider of AI-powered knowledge management and customer experience solutions, today announced that CEO Ashu Roy an
Aehr Test Systems to Participate in the 11th Annual Oppenheimer Emerging Growth Conference on February 3, 2026
07:30am, Tuesday, 27'th Jan 2026
FREMONT, CA / ACCESS Newswire / January 27, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), dat
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
04:30pm, Wednesday, 21'st Jan 2026
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference.
